The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. ENDRA Life Sciences Inc.’s current trading price is -83.38% away from its 52-week high, while its distance from the 52-week low is 26.80%. The stock’s price range for this period has been between $0.97 and $7.40 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 3.28 million for the day, a number notably higher than the average daily volume of 61590.0 over the last three months.
The stock of ENDRA Life Sciences Inc. (NDRA) is currently priced at $1.23. In the last session, the stock climbed significantly, topping out at $1.42 after opening at $1.00. The day’s lowest price was $0.96 before the stock closed at $1.02.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
ENDRA Life Sciences Inc. ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $7.40 on 09/16/22, while the lowest value for the same period was recorded at $0.97 on 09/14/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
ENDRA Life Sciences Inc. (NDRA) has experienced a quarterly decline of -16.33% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 8.78M and boasts a workforce of 21 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.3693, with a change in price of -0.5700. Similarly, ENDRA Life Sciences Inc. recorded 95,417 in trading volume during the last 100 days, posting a change of -31.67%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for NDRA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
NDRA Stock Stochastic Average
As of today, ENDRA Life Sciences Inc.’s raw stochastic average for the last 50 days stands at 39.71%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 58.70%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 35.89% and 32.99%, respectively.
NDRA Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant loss of -69.78% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -65.83%. Over the past 30 days, the price of NDRA has fallen by 6.96%. And in the last five days, it has surged by 8.84%.
